MORGANTI, STEFANIA
 Distribuzione geografica
Continente #
EU - Europa 1.654
NA - Nord America 683
AS - Asia 551
SA - Sud America 30
AF - Africa 25
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.959
Nazione #
DE - Germania 862
US - Stati Uniti d'America 639
IT - Italia 225
CN - Cina 208
GB - Regno Unito 199
SE - Svezia 130
IN - India 98
IE - Irlanda 62
SG - Singapore 54
FR - Francia 40
HK - Hong Kong 34
JP - Giappone 30
CA - Canada 26
ES - Italia 26
TR - Turchia 25
VN - Vietnam 21
ID - Indonesia 20
MX - Messico 18
KR - Corea 16
NL - Olanda 16
BR - Brasile 15
FI - Finlandia 13
PL - Polonia 13
BE - Belgio 12
CH - Svizzera 12
EG - Egitto 11
AU - Australia 10
PK - Pakistan 8
UA - Ucraina 8
MY - Malesia 6
RU - Federazione Russa 6
ZA - Sudafrica 6
AM - Armenia 5
CO - Colombia 5
DK - Danimarca 5
PH - Filippine 5
AR - Argentina 4
GR - Grecia 4
IL - Israele 4
IR - Iran 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
KE - Kenya 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
HR - Croazia 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
CL - Cile 1
EE - Estonia 1
LB - Libano 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.959
Città #
Frankfurt am Main 790
Southend 159
Chandler 148
Milan 72
Dublin 61
Ashburn 39
Princeton 38
New York 36
Fairfield 28
Beijing 27
Hong Kong 26
Ann Arbor 23
Istanbul 21
Shanghai 21
Cambridge 19
Hyderabad 19
Toronto 19
Bengaluru 16
Berlin 14
Singapore 14
Wilmington 14
Grafing 13
Rome 13
Des Moines 12
Helsinki 12
Houston 11
Jakarta 11
Seoul 10
Brussels 9
Chennai 9
Phoenix 9
Barcelona 8
Gdansk 8
Redwood City 8
Seattle 8
Boston 7
San Diego 7
Bologna 6
Curitiba 6
Fremont 6
Hangzhou 6
London 6
Wuhan 6
Cairo 5
Cape Town 5
Kuala Lumpur 5
Lanester 5
Mexico City 5
Nanjing 5
Rho 5
San Jose 5
Tokyo 5
Valencia 5
Woodbridge 5
Yerevan 5
Beersheba 4
Bühl 4
Dearborn 4
Delhi 4
Madrid 4
Nizhniy Novgorod 4
Nuremberg 4
Paris 4
Pordenone 4
Predazzo 4
Pune 4
Seregno 4
Tianjin 4
Turin 4
Ambler 3
Athens 3
Auckland 3
Bari 3
Boardman 3
Brisbane 3
Buenos Aires 3
Buffalo 3
Central District 3
Falls Church 3
Genoa 3
Gravesend 3
Groningen 3
Högsby 3
Karachi 3
Los Angeles 3
Madison 3
Manchester 3
Mit Ghamr 3
Munich 3
Nagazumi 3
Ponte Vedra Beach 3
Redmond 3
Roxbury 3
Santa Teresa di Riva 3
Steamboat Springs 3
Sydney 3
Terni 3
Upper Marlboro 3
Virginia Beach 3
Amsterdam 2
Totale 2.003
Nome #
Biologic therapy for advanced breast cancer : recent advances and future directions 366
Margetuximab for the treatment of HER2-positive metastatic breast cancer 339
Antibody–drug conjugates in solid tumors: a look into novel targets 183
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 149
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 122
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials 121
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 116
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 102
HER2-Low Breast Cancer: Pathological and Clinical Landscape 98
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management 95
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials 94
What therapies are on the horizon for HER2 positive breast cancer? 93
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 93
Master protocols in immuno-oncology : Do novel drugs deserve novel designs? 92
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2 90
Combinations using checkpoint blockade to overcome resistance 86
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 85
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy : A critical review of published data 80
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 79
Optimizing treatment strategy in early breast cancer: less is more, or more is better? 69
Clinical development and current role of margetuximab for the treatment of breast cancer 62
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 60
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 57
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari. 54
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 53
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 50
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist 45
Characterization of low HER2 expressions in de-novo metastatic breast cancer 45
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 45
COVID-19 related risk in patients enrolled in early-phase clinical trials 44
null 3
null 3
Totale 3.073
Categoria #
all - tutte 8.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 2 0 6 9 0 4 3 1 10 6 1 0
2020/2021313 23 16 5 10 14 14 17 23 51 52 49 39
2021/2022586 41 48 22 33 56 59 26 51 90 40 48 72
2022/2023766 77 79 76 61 80 107 28 39 98 34 58 29
2023/20241.361 33 43 41 68 139 82 205 174 98 171 210 97
Totale 3.073